Inconsistent alignment with WHO TRS during API sourcing – WHO inspector expectations explained



Published on 28/01/2026

Addressing Inconsistencies with WHO TRS in API Sourcing: A Practical Playbook

The pharmaceutical industry faces increasing scrutiny regarding the alignment with World Health Organization (WHO) Technical Reports Series (TRS) during Active Pharmaceutical Ingredient (API) sourcing. Inconsistent practices can lead to significant regulatory non-compliance, disrupted product manufacturing, and delays in market access. In this playbook, we will equip your team with actionable strategies to identify signals of non-compliance, investigate root causes, implement corrective actions, and ensure inspection readiness.

By following this playbook, professionals involved in production, quality control (QC), quality assurance (QA), engineering, and regulatory affairs (RA) will be better prepared to address inconsistencies in API sourcing and align with WHO standards effectively. You will learn how to quickly triage problems, conduct thorough investigations, establish robust controls, and maintain documentation that stands up to regulatory scrutiny.

Symptoms/Signals on the Floor or in the Lab

Identifying signs of inconsistent alignment with WHO TRS during API sourcing

requires keen observation and documentation. Below are common symptoms that can indicate potential non-compliance:

  • Increased Deviations: Record an uptick in deviations or non-conformance reports associated with API quality.
  • Out-of-Specification (OOS) Results: Frequent OOS results during testing phases related to sourcing batches could signify issues.
  • Supplier Audits: Findings from recent supplier audits that note deficiencies or lack of compliance with WHO guidelines.
  • Customer Complaints: An increase in complaints related to product efficacy or quality could point towards sourcing issues.
  • Inconsistent Testing Records: Variability in testing methodologies or discrepancies in batch records during routine quality checks.

Likely Causes

Understanding the root causes of inconsistencies in API sourcing requires a structured approach. Potential causes can be categorized into the following areas:

Materials

  • Substandard quality from suppliers
  • Lack of robust documentation from API manufacturers

Method

  • Inadequate testing protocols or failure to adhere to established methods
  • Improper techniques used during API sourcing
Pharma Tip:  WHO GMP gap identified during remediation planning – avoiding repeat WHO observations

Machine

  • Malfunctioning equipment used in the sourcing and testing of APIs
  • Outdated or uncalibrated testing machinery

Man

  • Insufficient training on WHO TRS compliance among staff
  • Lack of awareness regarding GMP standards and expectations

Measurement

  • Inconsistent measurement tools that may lead to errors in data collection
  • Discrepancies in data analysis leading to incorrect conclusions

Environment

  • Poor storage conditions for APIs affecting quality
  • Inadequate control of temperature or humidity in sourcing facilities

Immediate Containment Actions (First 60 Minutes)

Addressing reports of inconsistent alignment requires immediate containment to mitigate risk. Here are recommended actions within the first hour:

  • Activate the Response Team: Assemble a cross-functional team across production, QC, QA, and engineering.
  • Isolate Affected Batches: Halt further use of implicated API batches and quarantine products to prevent distribution.
  • Communicate Internally: Ensure all relevant stakeholders are informed about the issue to prevent misinformation.
  • Document Initial Findings: Keep records of deviations and relevant observations immediately to establish a data trail.
  • Notify Suppliers: Contact API suppliers to discuss immediate actions, including their investigation process.

Investigation Workflow

After immediate containment, a thorough investigation is essential. Follow these steps to ensure a systematic approach:

  1. Define the Problem: Clearly articulate the nature of the inconsistency – e.g., specific failing criteria related to WHO TRS.
  2. Data Collection: Gather all relevant data, including batch records, test results, supplier certificates, and audit findings.
  3. Data Analysis: Interpret the data against industry standards, noting any trends or patterns that align with known deficiencies.
  4. Engage Stakeholders: Solicit input from team members across departments to gain a comprehensive understanding of the issue.

Root Cause Tools

Utilize effective root cause analysis tools to determine the underlying issues contributing to inconsistencies. Here are three recognized methodologies:

5-Why Analysis

This technique involves asking “why” five times to drill down to the core of an issue. It is particularly useful for straightforward problems where simple cause-and-effect relationships are apparent.

Fishbone Diagram (Ishikawa)

The Fishbone diagram helps visually map out different cause categories (e.g., materials, methods) and can be valuable for complex issues where multiple factors contribute to inconsistencies.

Fault Tree Analysis

This method provides a top-down approach to exploration, identifying potential failure pathways related to discrepancies. It is suitable for critical processes where systemic issues must be addressed.

Pharma Tip:  Inadequate WHO GMP training during API sourcing – evidence pack for WHO audits

CAPA Strategy

Once the root cause is identified, establish a Corrective and Preventive Action (CAPA) strategy. Components include:

Correction: Rectify the immediate problem(s) identified, such as re-evaluating the affected batches or conducting immediate retesting.

Corrective Action: Implement actions to address the root cause, which may involve retraining staff, revising procedures, or enhancing supplier audits.

Preventive Action: Develop strategies to prevent recurrence. This can include robust supplier qualification processes, regular training sessions, and updated testing protocols in line with WHO GMP compliance standards.

Control Strategy & Monitoring

Ensuring continued compliance with WHO GMP requires appropriate control measures and ongoing monitoring:

  • Statistical Process Control (SPC): Implement SPC techniques to monitor quality metrics consistently and detect variations that may indicate non-compliance.
  • Sampling Plans: Define sampling plans that are representative of the batch and statistically relevant, ensuring that the data is actionable.
  • Alarm Systems: Set critical alarms that trigger responses for out-of-control processes during API sourcing and testing.
  • Verification Processes: Regularly revisit and validate all phases of the workflow to ensure adherence to compliance standards.

Validation / Re-qualification / Change Control Impact

Depending on the findings, organizations may need to reassess validation and qualification statuses:

Related Reads

  • Validation: Review all validation documentation to ensure that processes remain compliant with WHO TRS and any gaps are addressed.
  • Re-qualification: If significant changes are made as a result of the investigation, consider re-qualifying affected processes to verify consistent output quality.
  • Change Control: Implement a robust change control mechanism to manage any modifications to sourcing practices and assess potential impacts on product quality.

Inspection Readiness: What Evidence to Show

To achieve inspection readiness post-investigation, gather comprehensive documentation and evidence:

  • Records of Deviations: Maintain detailed logs of all deviations, corrective actions taken, and preventive measures implemented.
  • Batch Documentation: Ensure complete batch records support traceability and provide evidence of compliance during sourcing.
  • Training Records: Document training sessions that align with WHO TRS guidelines and demonstrate the competency of staff.
  • Audit Findings: Include both internal and supplier audit results highlighting compliance status and corrective actions from previous audits.
Pharma Tip:  Inconsistent alignment with WHO TRS during internal gap assessment – WHO inspector expectations explained

FAQs

What is WHO TRS and why is it important for API sourcing?

WHO TRS provides guidelines and standards for the manufacture of quality pharmaceutical products, ensuring APIs sourced meet international standards.

How do we identify if our API supplier complies with WHO GMP?

Conduct regular audits, assess documentation for compliance with WHO guidelines, and require certification of compliance from the supplier.

What immediate actions should we take if we identify potential non-compliance?

Activate a response team, isolate affected batches, and document initial findings while notifying relevant internal and external stakeholders.

What tools can help in conducting a root cause analysis?

Utilize 5-Why analysis, Fishbone diagrams, and Fault Tree analysis to effectively identify underlying causes of inconsistencies.

How can we ensure ongoing compliance in our API sourcing process?

Implement a robust control strategy with regular monitoring, including statistical process control, validation, and training of personnel.

What records should be maintained for inspection readiness?

Maintain records including deviations, batch documentation, training logs, and audit findings to demonstrate compliance and proactive quality management.

How often should we evaluate our API sourcing practices?

Regular evaluations should occur at least annually or after significant changes to sourcing practices, equipment, or supplier relationships.

What is the impact of inconsistent API sourcing on product quality?

Inconsistent sourcing can lead to variability in product quality, increasing the risk of non-compliance and potential regulatory action.

Can changes in our sourcing strategy affect our validation status?

Yes, changes in sourcing strategy can necessitate a reevaluation of validation statuses to ensure ongoing compliance with relevant regulations and standards.

What is the role of training in avoiding compliance issues?

Regular training ensures that all staff are aware of and adhere to GMP standards, thereby reducing the risk of human error in alignment with requirements.

How do we effectively communicate compliance issues within our organization?

Establish clear lines of communication among departments and ensure that all team members are aware of the potential implications and necessary actions related to compliance issues.

How can statistical trend analysis assist in monitoring compliance?

Statistical trend analysis helps identify patterns that signal deviations from compliance, facilitating timely corrective actions and process adjustments.